clinical trial semaglutide Flow chart of participants in the STEP 5 trial s.c., Efficacy and safety of once-daily

If protein intake was too low, strength training was minimal, or muscle mass declined, the metabolic foundation remains fragile once medication support is removed

10:00 17:00 , ,

Uldry M

We critically evaluate clinical evidence across major liver diseases, including viral hepatitis, drug-induced liver injury, alcoholic liver disease, non-alcoholic fatty liver disease, and autoimmune hepatitis, while highlighting heterogeneity in study designs, geographical concentration of evidence, and the predominance of positive findings that may reflect publication bias

Biochimica et Biophysica Acta (BBA) 1870(5):119452 Zeng F, Nijiati S, Tang L, Ye J, Zhou Z, Chen X (2023) Ferroptosis detection: from approaches to applications